Headlines about Intermolecular (NASDAQ:IMI) have trended positive this week, according to Accern. The research firm scores the sentiment of press coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Intermolecular earned a daily sentiment score of 0.28 on Accern’s scale. Accern also assigned media coverage about the semiconductor company an impact score of 47.1498680122132 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

Shares of Intermolecular (NASDAQ IMI) traded up $0.03 during mid-day trading on Tuesday, hitting $1.25. The company’s stock had a trading volume of 5,000 shares, compared to its average volume of 77,304. Intermolecular has a one year low of $0.80 and a one year high of $1.65. The stock has a market cap of $60.46, a P/E ratio of -4.46 and a beta of 1.16.

Separately, ValuEngine upgraded Intermolecular from a “sell” rating to a “hold” rating in a research note on Sunday, December 31st.

WARNING: This article was originally reported by Watch List News and is owned by of Watch List News. If you are accessing this article on another publication, it was illegally copied and republished in violation of US & international copyright & trademark law. The original version of this article can be viewed at https://www.watchlistnews.com/intermolecular-imi-earns-news-impact-score-of-0-28/1863818.html.

Intermolecular Company Profile

Intermolecular, Inc provides thin film solutions. The Company’s high productivity combinatorial (HPC) platform, which consists of its tempus processing tools, its automated characterization methods, and its Informatics analysis software, is purpose-built for research and development (R&D) using combinatorial process systems.

Insider Buying and Selling by Quarter for Intermolecular (NASDAQ:IMI)

Receive News & Ratings for Intermolecular Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intermolecular and related companies with MarketBeat.com's FREE daily email newsletter.